Garin denies negotiating for Dengvaxia price | Inquirer News

Garin denies negotiating for Dengvaxia price

/ 02:02 PM December 14, 2017

Dr. Janette Loreto-Garin

Former DOH Secretary Janette Loreto-Garin answers questions from Senator Gordon during the Dec. 14, 2017, Senate hearing on the Dengvaxia vaccine. PHILIPPINE DAILY INQUIRER / EDWIN BACASMAS

Former Health Secretary Janette Garin denied negotiating with Sanofi Pasteur on the price of the anti-dengue vaccine in an attempt to reduce its cost.

During the joint hearing of the Senate blue ribbon, health and finance committees on Thursday, Senator Richard Gordon asked if Garin negotiated with the French pharmaceutical giant to reduce the cost of the Dengvaxia vaccine in 2015.

ADVERTISEMENT

“I strongly deny that. I did not negotiate with the price, but Sanofi came to the Philippines and presented their proposal to the government,” Garin said.

FEATURED STORIES

She narrated that she was late during the meeting, but some Department of Health (DOH) directors and an undersecretary were already there.

“So I came last in the meeting but I made a joke your honor because it was already at the end of the meeting. I said just update me and I said sana po buy one take one ‘yan if the private buys one, give one to the government,” she said.

“But I never negotiated for the price because we didn’t have money (at that time),” she added.

The P3.5 billion vaccination drive was launched in 2016 when Garin was still health chief.

According to the timeline of events submitted by former DOH Secretary Paulyn Rosell-Ubial to the Senate panels, Garin “negotiated with Sanofi to reduce the cost of the vaccines on June 9, 2015.”

The alleged negotiation, according to the timeline, happened after Garin went to Paris, France on May 14, 2015 and met with Sanofi Pasteur officials and discussed the vaccine’s cost over dinner.

ADVERTISEMENT

This meeting was followed by Sanofi’s submission on Oct. 29 of an application to include the dengue vaccine in the Philippine National Formulary (PNF) pending the Certificate of Product Registration (CPR) issuance of the Food and Drug Administration (FDA). /cbb

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: dengue, Dengvaxia, DoH, News, Senate

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.